Opicapone for the treatment of Parkinson's disease: A review of a new licensed medicine-Reference-Cited by-同舟云学术

Opicapone for the treatment of Parkinson's disease: A review of a new licensed medicine

Published:2018-09-27 Issue:10 Volume:33 Page:1528-1539
ISSN:0885-3185
Container-title:Movement Disorders
language:en
Short-container-title:Mov Disord.

Author:

Fabbri Margherita¹,Ferreira Joaquim J.¹²³,Lees Andrew⁴,Stocchi Fabrizio⁵,Poewe Werner⁶,Tolosa Eduardo⁷,Rascol Olivier⁸

Affiliation:

1. Instituto de Medicina Molecular; Lisbon Portugal

2. Laboratory of Clinical Pharmacology and Therapeutics, Faculty of Medicine; University of Lisbon; Lisbon Portugal

3. CNS - Campus Neurológico Sénior; Torres Vedras Portugal

4. The National Hospital; Queen Square London UK

5. University and Institute for Research and Medical Care, IRCCS San Raffaele; Rome Italy

6. Department of Neurology; Innsbruck Medical University; Innsbruck Austria

7. Movement Disorder Unit, Neurology Service, Hospital Clínic of Barcelona, IDIBAPS, CIBERNED; Barcelona Spain

8. Departments of Clinical Pharmacology and Neurosciences, Clinical Investigation Center CIC 1436, NS-Park/FCRIN network and NeuroToul COEN Center, INSERM, CHU de Toulouse, Université de Toulouse 3; Toulouse France

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/mds.27475/fullpdf

Reference74 articles.

1. Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030;Dorsey;Neurology,2007

2. Levodopa therapy for Parkinson's disease: pharmacokinetics and pharmacodynamics;LeWitt;Mov Disord,2015

3. Dyskinesias and motor fluctuations in Parkinson's disease. A community-based study;Schrag;Brain,2000

4. Clinical spectrum of levodopa-induced complications;Aquino;Mov Disord,2015

5. Factors predictive of the development of Levodopa-induced dyskinesia and wearing-off in Parkinson's disease;Warren Olanow;Mov Disord,2013

Cited by 83 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacotherapy of motor symptoms in early and mid-stage Parkinson’s disease: guideline “Parkinson’s disease” of the German Society of Neurology;Journal of Neurology;2024-08-29

2. Drug Development for Alzheimer’s and Parkinson’s Disease: Where Do We Go Now?;Pharmaceutics;2024-05-24

3. Catechol-O-methyltransferase and monoamine oxidase B inhibitory activities of Australian bee pollen;Bioscience, Biotechnology, and Biochemistry;2024-04-01

4. Levodopa–Entacapone–Carbidopa Intestinal Gel in the Treatment of Advanced Parkinson’s Disease: A Single Center Real-World Experience;Pharmaceutics;2024-03-25

5. Recent Drugs Tested in Clinical Trials for Alzheimer´s and Parkinson´s Diseases Treatment: Current Approaches in Tracking New Drugs;Frontiers in Clinical Drug Research - CNS and Neurological Disorders;2024-03-10